We are live on ! Find out more
AC

Arjuna Capital Portfolio holdings

AUM $393M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
+1.51%
1 Year Est. Return
+20.42%
3 Year Est. Return
+74.87%
5 Year Est. Return
+103.01%
10 Year Est. Return
AUM
$376M
AUM Growth
-$10.3M
Cap. Flow
-$10M
Cap. Flow %
-2.67%
Top 10 Hldgs %
43.88%
Holding
112
New
9
Increased
32
Reduced
54
Closed
13

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$3.1M
2
CSCO icon
Cisco
CSCO
+$2.93M
3
TJX icon
TJX Companies
TJX
+$1.79M
4
CMCSA icon
Comcast
CMCSA
+$1.79M
5
BXP icon
Boston Properties
BXP
+$1.58M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$3.93M
2
AMT icon
American Tower
AMT
+$3.34M
3
LRCX icon
Lam Research
LRCX
+$2.46M
4
DGX icon
Quest Diagnostics
DGX
+$2.3M
5
CNC icon
Centene
CNC
+$2.1M

Sector Composition

Rank Sector Weight
1 Technology 31.97%
2 Financials 14.86%
3 Consumer Discretionary 11.32%
4 Healthcare 10.62%
5 Communication Services 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APOG icon
26
Apogee Enterprises
APOG
$822M
$4.45M 1.18%
62,252
-469
-0.7% -$36.8K
CMCSA icon
27
Comcast
CMCSA
$84.1B
$4.05M 1.08%
107,786
+43,030
+66% +$1.79M
SFM icon
28
Sprouts Farmers Market
SFM
$8.06B
$3.97M 1.06%
31,252
-5,339
-15% -$710K
PSA icon
29
Public Storage
PSA
$59.3B
$3.93M 1.04%
13,109
-29
-0.2% -$9.62K
CWT icon
30
California Water Service
CWT
$3.05B
$3.85M 1.02%
84,911
+16,235
+24% +$820K
MA icon
31
Mastercard
MA
$504B
$3.78M 1.01%
7,175
-190
-3% -$98.4K
TSLA icon
32
Tesla
TSLA
$1.2T
$3.74M 1%
9,266
+943
+11% +$303K
V icon
33
Visa
V
$680B
$3.67M 0.98%
11,628
-246
-2% -$74K
TJX icon
34
TJX Companies
TJX
$175B
$3.59M 0.96%
29,734
+14,999
+102% +$1.79M
VZ icon
35
Verizon
VZ
$194B
$3.47M 0.92%
86,789
-2,167
-2% -$91.4K
NVO
36
Novo Nordisk
NVO
$206B
$3.23M 0.86%
37,517
-9,750
-21% -$1.05M
LOW icon
37
Lowe's Companies
LOW
$116B
$3.12M 0.83%
12,626
-250
-2% -$66.8K
RGA icon
38
Reinsurance Group of America
RGA
$15.6B
$3.08M 0.82%
14,426
-571
-4% -$125K
CSCO icon
39
Cisco
CSCO
$451B
$3.03M 0.81%
+51,226
New +$2.93M
BCO icon
40
Brink's
BCO
$4.72B
$3.03M 0.81%
32,654
+74
+0.2% +$7.4K
PGR icon
41
Progressive
PGR
$124B
$2.97M 0.79%
12,384
+5,959
+93% +$1.5M
NUE icon
42
Nucor
NUE
$58.6B
$2.89M 0.77%
24,772
+312
+1% +$44.9K
NFLX icon
43
Netflix
NFLX
$299B
$2.72M 0.73%
30,570
-1,280
-4% -$105K
KMB icon
44
Kimberly-Clark
KMB
$36.3B
$2.7M 0.72%
20,608
-416
-2% -$56.7K
IBM icon
45
IBM
IBM
$205B
$2.61M 0.7%
11,892
+4,257
+56% +$948K
VRTX icon
46
Vertex Pharmaceuticals
VRTX
$120B
$2.23M 0.59%
5,541
+68
+1% +$31.5K
EXPD icon
47
Expeditors International
EXPD
$22B
$2.17M 0.58%
19,632
-393
-2% -$46.9K
HPQ icon
48
HP
HPQ
$24.5B
$2.16M 0.58%
66,272
-2,092
-3% -$75.2K
ESGV icon
49
Vanguard ESG US Stock ETF
ESGV
$13B
$2.13M 0.57%
20,298
-13,056
-39% -$1.37M
CAH icon
50
Cardinal Health
CAH
$53.6B
$2.09M 0.56%
17,712
-572
-3% -$66.8K

Similar funds

Arjuna Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Arjuna Capital held 112 positions worth $376M, down 2.7% from $386M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Arjuna Capital's Q4 2024 filing shows 9 new, 32 increased, 54 reduced and 13 closed positions. Its largest new stake was Cisco: 51,226 shares worth $3.03M. The largest sale was Colgate-Palmolive, an estimated $3.93M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Arjuna Capital's largest Q4 2024 buy was Cisco: 51,226 shares worth $3.03M.
  • Arjuna Capital added most to GSK in Q4 2024, an estimated $3.1M increase.
  • Arjuna Capital's biggest Q4 2024 reduction was Quest Diagnostics, cutting an estimated $2.3M.
  • Arjuna Capital fully exited Colgate-Palmolive in Q4 2024, selling an estimated $3.93M.
  • Arjuna Capital's ten largest holdings make up 44% of its $376M portfolio in Q4 2024.
  • Arjuna Capital opened 9 new positions and closed 13 in Q4 2024.
  • Arjuna Capital's portfolio value fell 2.7% quarter-over-quarter to $376M.

Based on Arjuna Capital's 13F filing for Q4 2024, filed 7 Feb 2025.